Autonomic Dysfunction
Autonomic dysfunction is present in 70–90% of ME/CFS patients (Newton et al. 2007), manifesting as ortho-static in-tolerance, temperature dys-regulation, and cardio-vascular symptoms.
1 Orthostatic Intolerance
Orthostatic intolerance (OI) refers to symptoms triggered or worsened by upright posture. It is one of the most common and disabling features of ME/CFS autonomic dysfunction.
1.1 Clinical Presentation
Symptoms upon standing or prolonged sitting include:
- Lightheadedness or dizziness: Feeling faint, vision graying out
- Palpitations: Awareness of rapid or pounding heartbeat
- Tremulousness: Shaking, feeling weak or unstable
- Cognitive impairment: “Coat hanger pain” (neck/shoulder aching from reduced cerebral perfusion)
- Nausea: Gastrointestinal symptoms triggered by position change
- Shortness of breath: Air hunger despite normal oxygen saturation
- Fatigue exacerbation: Profound worsening of exhaustion when upright
Patients often develop adaptive behaviors: sitting while showering, lying down frequently, avoiding standing in lines, preferring reclined positions.
1.2 Postural Orthostatic Tachycardia Syndrome (POTS)
POTS is the most common form of orthostatic intolerance in ME/CFS, affecting 25–50% of patients (Hoad et al. 2008).
Diagnostic Criteria.
- Heart rate increase: \(\geq\) 30 bpm within 10 minutes of standing (or \(\geq\) 40 bpm in adolescents) (Sheldon et al. 2015)
- Absence of orthostatic hypotension: Blood pressure remains stable or increases
- Symptom provocation: OI symptoms occur with the tachycardia
- Duration: Symptoms present for \(\geq\) 3 months
- Exclusions: No other cause (dehydration, medications, prolonged bed rest alone)
Physiological Mechanisms. POTS in ME/CFS may involve:
- Hypovolemia: Reduced blood volume (measured via Evans blue dye dilution studies)
- Venous pooling: Impaired vasoconstriction allows blood to pool in lower extremities
- Hyperadrenergic state: Excessive norepinephrine release upon standing
- Baroreceptor dysfunction: Impaired blood pressure sensing
- Autoimmunity: Antibodies against adrenergic and muscarinic receptors affecting vascular tone
Measurement.
- NASA Lean Test: 10-minute standing test measuring heart rate and blood pressure every 2 minutes
- Tilt table testing: Gold standard, involves passive upright tilt to 70° for up to 45 minutes
- Home monitoring: Patients can document HR/BP changes with home devices
1.3 Orthostatic Hypotension (OH)
Less common than POTS but present in some ME/CFS patients:
- Definition: Sustained drop in systolic BP \(\geq\) 20 mmHg or diastolic BP \(\geq\) 10 mmHg within 3 minutes of standing
- Symptoms: Severe lightheadedness, syncope, visual blurring, cognitive impairment
- Mechanism: Inadequate vasoconstriction response to postural change
- Treatment: Different from POTS; requires blood pressure support (fludrocortisone, midodrine)
1.4 Neurally Mediated Hypotension (NMH)
Also called vasovagal syncope or neurocardiogenic syncope:
- Presentation: Delayed blood pressure drop and bradycardia after prolonged standing (typically 15–45 minutes)
- Mechanism: Paradoxical vagal activation causing vasodilation and heart rate slowing
- Tilt table pattern: Initial normal response, then sudden BP/HR drop with near-syncope
- Overlap: Can coexist with POTS in same patient
1.5 Tilt Table Testing Protocol
The gold standard for diagnosing orthostatic intolerance:
- Preparation: Patient lies supine on motorized table with footboard support
- Baseline: 10–20 minutes supine to establish baseline HR and BP
- Tilt: Table tilted to 70° head-up position
- Monitoring: Continuous HR, BP, and symptoms recorded for up to 45 minutes
- Endpoints: Test terminated if syncope occurs, BP drops dangerously, or maximum duration reached
Interpretation.
- POTS pattern: Sustained HR increase \(\geq\) 30 bpm without BP drop
- Orthostatic hypotension: BP drop within 3 minutes
- NMH pattern: Delayed sudden BP/HR drop after 15–45 minutes
- Normal response: HR increase <30 bpm, stable BP
Clinical note: Some ME/CFS patients have severe OI symptoms with “normal” tilt table results. This may reflect:
- Cerebral hypoperfusion despite maintained BP (impaired cerebral autoregulation)
- Small fiber neuropathy not detected by standard autonomic testing
- Endothelial dysfunction affecting microvascular perfusion
2 Other Autonomic Symptoms
Beyond orthostatic intolerance, ME/CFS patients experience widespread autonomic dysfunction:
2.1 Temperature Dysregulation
Impaired thermoregulation manifests as:
- Subnormal body temperature: Chronic low-grade hypothermia (96–97°F / 35.5–36°C)
- Temperature instability: Fluctuations throughout day without infection
- Heat intolerance: Severe symptom exacerbation in warm environments; heat stress can precipitate PEM through circulatory demands and metabolic stress
- Cold intolerance: Inability to warm up, cold extremities even in warm rooms
- Inappropriate sweating: Night sweats, profuse sweating with minimal exertion
- Lack of sweating: Some patients lose ability to sweat (anhidrosis)
Mechanism. Thermoregulatory dysfunction reflects hypothalamic autonomic pathway disruption plus peripheral vascular dysregulation. Cambras et al. (2023) demonstrated that skin temperature circadian rhythm alterations in ME/CFS are associated with elevated endothelin-1 (ET-1) levels (\(p < 0.01\)), linking vascular tone dysregulation directly to thermoregulatory failure (Cambras et al. 2023). Stanculescu et al. (2021) identified that ME/CFS and heat stroke share at least 9 pathophysiological mechanisms (gut permeability, endotoxemia, endothelial dysfunction, mitochondrial impairment, HSP deficiency), suggesting that heat intolerance in ME/CFS reflects a pre-existing vulnerability to thermal stress rather than a simple perception abnormality (Stanculescu et al. 2021).
2.2 Sweating Abnormalities
Thermoregulatory and sympathetic sweating dysfunction:
- Hyperhidrosis: Excessive sweating of hands, feet, or generalized
- Hypohidrosis/anhidrosis: Reduced or absent sweating capacity
- Gustatory sweating: Sweating triggered by eating (cranial autonomic dysfunction)
- Night sweats: Drenching sweats during sleep requiring clothing/bedding changes
2.3 Gastrointestinal Symptoms
Autonomic control of GI function is commonly impaired:
- Gastroparesis: Delayed gastric emptying causing early satiety, nausea, bloating. Delayed gastric emptying has been measured in a ME/CFS cohort and correlated with symptom severity (Burnet and Chatterton 2004).
- Irritable Bowel Syndrome (IBS): Diarrhea-predominant, constipation-predominant, or alternating
- Dysmotility: Impaired intestinal peristalsis
- Nausea: Chronic or episodic, often worse upon standing (orthostatic nausea)
- Abdominal pain: Cramping, visceral hypersensitivity
2.4 Urinary Dysfunction
Bladder autonomic control abnormalities include:
- Urgency and frequency: Needing to urinate frequently with sudden urgency
- Nocturia: Waking multiple times at night to urinate
- Incomplete emptying: Sensation of residual urine
- Interstitial cystitis overlap: Bladder pain, pressure, frequency
2.5 Cardiac Symptoms
Beyond POTS-related tachycardia:
- Inappropriate sinus tachycardia: Resting heart rate >100 bpm without postural trigger
- Palpitations: Awareness of heartbeat, skipped beats, forceful beats
- Chest pain: Non-cardiac chest pain (microvascular angina, costochondritis)
- Heart rate variability reduction: Reduced parasympathetic tone
- Exercise intolerance: Exaggerated HR response to minimal exertion
2.6 Pupillary Abnormalities
Autonomic control of pupils may be affected:
- Light sensitivity (photophobia): Inability to tolerate bright lights
- Impaired pupil constriction: Sluggish response to light
- Anisocoria: Unequal pupil sizes
3 Autonomic Testing Battery
Comprehensive autonomic function assessment may include:
- Tilt table test: Orthostatic intolerance assessment
- Valsalva maneuver: Tests baroreceptor and cardiovagal function
- Deep breathing test: Measures heart rate variability during paced breathing
- Quantitative sudomotor axon reflex test (QSART): Assesses sweating capacity
- Thermoregulatory sweat test: Maps sweating across entire body
- Pupillometry: Automated pupil response measurement
- Skin biopsy: Small fiber neuropathy assessment (intraepidermal nerve fiber density)
Many ME/CFS specialty centers lack access to full autonomic testing, making tilt table and basic orthostatic vitals the most commonly used assessments.
4 Clinical Implications
Autonomic dysfunction in ME/CFS is:
- Objectively measurable: Tilt table, HRV, and other tests provide objective abnormalities
- Highly disabling: OI can prevent standing long enough to shower or prepare meals
- Treatable: Salt, fluids, compression, and medications can significantly improve symptoms
- Not anxiety: Patients are often told POTS is anxiety; it is a physiological abnormality
- Connected to energy metabolism: Autonomic dysfunction may reflect mitochondrial impairment in autonomic neurons
Recognition and treatment of dysautonomia is often the first step in improving ME/CFS functional capacity.